<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC7267920</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC7267920.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">7267920</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">7267920</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">31778276</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1002/hbm.24878</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">HBM24878</article-id></all-ids><extracted-table><table-id>hbm24878-tbl-0001</table-id><table-label>Table 1</table-label><table-caption>Review of articles that have performed diffusion MRI analysis on the substantia nigra pars compacta in Parkinson's disease</table-caption><table-wrap-foot>Abbreviations: ↑: Increase; ↓: Decrease; DTI: Diffusion Tensor Imaging; FA: Fractional Anisotropy; HC: Healthy Controls; MD: Mean Diffusivity; NM‐MRI: Neuromelanin Magnetic Resonance Imaging; NM‐T1: Neuromelanin sensitive T1; PD: Parkinson's disease; RD: Radial Diffusivity; ROI‐Region Of Interest; SNc: Substantia Nigra pars compacta; T1w: T1 weighted; T2w: T2 weighted.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hbm24878-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Review of articles that have performed diffusion MRI analysis on the substantia nigra pars compacta in Parkinson's disease</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Author (year)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sample size (DTI/NM‐MRI)</th><th align="left" valign="bottom" rowspan="1" colspan="1">ROI placement</th><th align="left" valign="bottom" rowspan="1" colspan="1">ROI image</th><th align="left" valign="bottom" rowspan="1" colspan="1">DTI results of PD in comparison to HC</th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top" rowspan="1"><italic toggle="yes"><bold>DTI studies with T1/Neuromelanin based SN contrast</bold></italic><bold>:</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Langley et al. (<xref rid="hbm24878-bib-0027" ref-type="ref">2016</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">20:17/11 (PD: HC /HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">NM‐T1, T2w</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓, MD↑ for NM‐T1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Menke, Jbabdi, Miller, Matthews, and Zarei (<xref rid="hbm24878-bib-0034" ref-type="ref">2010</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">10:10 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Semiautomatic</td><td align="left" valign="top" rowspan="1" colspan="1">T1w, DTI tracks</td><td align="left" valign="top" rowspan="1" colspan="1">No significance</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1"><italic toggle="yes"><bold>DTI studies with T2w/ T2*w image based SN contrast</bold></italic><bold>:</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Schwarz et al. (<xref rid="hbm24878-bib-0049" ref-type="ref">2013</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">32:27 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">T2w</td><td align="left" valign="top" rowspan="1" colspan="1">MD↑</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Du et al. (<xref rid="hbm24878-bib-0012" ref-type="ref">2011</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">16:16 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Semiautomatic</td><td align="left" valign="top" rowspan="1" colspan="1">T2w</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓, R2*↑</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Prakash et.al (<xref rid="hbm24878-bib-0541" ref-type="ref">2012</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">11:12 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">T2w</td><td align="left" valign="top" rowspan="1" colspan="1">FA asymmetry in SNc subregion in PD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rolheiser et al. (<xref rid="hbm24878-bib-0045" ref-type="ref">2011</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">14:14 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">T2w + V1 maps</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓, RD↑</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Peran et al. (<xref rid="hbm24878-bib-0040" ref-type="ref">2010</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">30:22 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">T2*w images</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓, R2*↑</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vaillancourt et al. (<xref rid="hbm24878-bib-0057" ref-type="ref">2009</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">14:14 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">T2w</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1"><italic toggle="yes"><bold>DTI studies with DTI based SN contrast</bold></italic><bold>:</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knossalla et al. (<xref rid="hbm24878-bib-0025" ref-type="ref">2018</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">10:10 (PD: HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">FA maps</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Asymmetry in SNc subregion</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Loane et al. (<xref rid="hbm24878-bib-0031" ref-type="ref">2016</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">18:14 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">FA, MD maps</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓, MD↑</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Schuff et al (<xref rid="hbm24878-bib-0549" ref-type="ref">2015</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">67:153 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">FA maps, T1w</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓ in rostral SNc, AD↑, RD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">No significance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aquino et al. (<xref rid="hbm24878-bib-0002" ref-type="ref">2014</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">42:20 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">Axial IR</td><td align="left" valign="top" rowspan="1" colspan="1">No significance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zhan et al. (<xref rid="hbm24878-bib-0060" ref-type="ref">2012</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">12:20 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Semiautomatic</td><td align="left" valign="top" rowspan="1" colspan="1">FA maps</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gattellaro et al. (<xref rid="hbm24878-bib-0016" ref-type="ref">2009</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">10:10 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">DTI tracks</td><td align="left" valign="top" rowspan="1" colspan="1">No significance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chan et al. (<xref rid="hbm24878-bib-0010" ref-type="ref">2007</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">73:78 (PD:HC)</td><td align="left" valign="top" rowspan="1" colspan="1">Manual</td><td align="left" valign="top" rowspan="1" colspan="1">FA maps</td><td align="left" valign="top" rowspan="1" colspan="1">FA↓</td></tr></tbody></table><table-wrap-foot id="hbm24878-ntgp-0001"><fn id="hbm24878-note-0001"><p>Abbreviations: ↑: Increase; ↓: Decrease; DTI: Diffusion Tensor Imaging; FA: Fractional Anisotropy; HC: Healthy Controls; MD: Mean Diffusivity; NM‐MRI: Neuromelanin Magnetic Resonance Imaging; NM‐T1: Neuromelanin sensitive T1; PD: Parkinson's disease; RD: Radial Diffusivity; ROI‐Region Of Interest; SNc: Substantia Nigra pars compacta; T1w: T1 weighted; T2w: T2 weighted.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Review of articles that have performed diffusion MRI analysis on the substantia nigra pars compacta in Parkinson's disease</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Author (year)</th><th align="left" valign="bottom">Sample size (DTI/NM‐MRI)</th><th align="left" valign="bottom">ROI placement</th><th align="left" valign="bottom">ROI image</th><th align="left" valign="bottom">DTI results of PD in comparison to HC</th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top">DTI studies with T1/Neuromelanin based SN contrast:</td></tr><tr><td align="left" valign="top">Langley et al. (???)</td><td align="left" valign="top">20:17/11 (PD: HC /HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">NM‐T1, T2w</td><td align="left" valign="top">FA↓, MD↑ for NM‐T1</td></tr><tr><td align="left" valign="top">Menke, Jbabdi, Miller, Matthews, and Zarei (???)</td><td align="left" valign="top">10:10 (PD: HC)</td><td align="left" valign="top">Semiautomatic</td><td align="left" valign="top">T1w, DTI tracks</td><td align="left" valign="top">No significance</td></tr><tr><td colspan="5" align="left" valign="top">DTI studies with T2w/ T2*w image based SN contrast:</td></tr><tr><td align="left" valign="top">Schwarz et al. (???)</td><td align="left" valign="top">32:27 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">T2w</td><td align="left" valign="top">MD↑</td></tr><tr><td align="left" valign="top">Du et al. (???)</td><td align="left" valign="top">16:16 (PD: HC)</td><td align="left" valign="top">Semiautomatic</td><td align="left" valign="top">T2w</td><td align="left" valign="top">FA↓, R2*↑</td></tr><tr><td align="left" valign="top">Prakash et.al (???)</td><td align="left" valign="top">11:12 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">T2w</td><td align="left" valign="top">FA asymmetry in SNc subregion in PD</td></tr><tr><td align="left" valign="top">Rolheiser et al. (???)</td><td align="left" valign="top">14:14 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">T2w + V1 maps</td><td align="left" valign="top">FA↓, RD↑</td></tr><tr><td align="left" valign="top">Peran et al. (???)</td><td align="left" valign="top">30:22 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">T2*w images</td><td align="left" valign="top">FA↓, R2*↑</td></tr><tr><td align="left" valign="top">Vaillancourt et al. (???)</td><td align="left" valign="top">14:14 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">T2w</td><td align="left" valign="top">FA↓</td></tr><tr><td colspan="5" align="left" valign="top">DTI studies with DTI based SN contrast:</td></tr><tr><td align="left" valign="top">Knossalla et al. (???)</td><td align="left" valign="top">10:10 (PD: HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">FA maps</td><td align="left" valign="top">FA↓</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Asymmetry in SNc subregion</td></tr><tr><td align="left" valign="top">Loane et al. (???)</td><td align="left" valign="top">18:14 (PD:HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">FA, MD maps</td><td align="left" valign="top">FA↓, MD↑</td></tr><tr><td align="left" valign="top">Schuff et al (???)</td><td align="left" valign="top">67:153 (PD:HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">FA maps, T1w</td><td align="left" valign="top">FA↓ in rostral SNc, AD↑, RD</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">No significance</td></tr><tr><td align="left" valign="top">Aquino et al. (???)</td><td align="left" valign="top">42:20 (PD:HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">Axial IR</td><td align="left" valign="top">No significance</td></tr><tr><td align="left" valign="top">Zhan et al. (???)</td><td align="left" valign="top">12:20 (PD:HC)</td><td align="left" valign="top">Semiautomatic</td><td align="left" valign="top">FA maps</td><td align="left" valign="top">FA↓</td></tr><tr><td align="left" valign="top">Gattellaro et al. (???)</td><td align="left" valign="top">10:10 (PD:HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">DTI tracks</td><td align="left" valign="top">No significance</td></tr><tr><td align="left" valign="top">Chan et al. (???)</td><td align="left" valign="top">73:78 (PD:HC)</td><td align="left" valign="top">Manual</td><td align="left" valign="top">FA maps</td><td align="left" valign="top">FA↓</td></tr></tbody></table></div>Abbreviations: ↑: Increase; ↓: Decrease; DTI: Diffusion Tensor Imaging; FA: Fractional Anisotropy; HC: Healthy Controls; MD: Mean Diffusivity; NM‐MRI: Neuromelanin Magnetic Resonance Imaging; NM‐T1: Neuromelanin sensitive T1; PD: Parkinson's disease; RD: Radial Diffusivity; ROI‐Region Of Interest; SNc: Substantia Nigra pars compacta; T1w: T1 weighted; T2w: T2 weighted.</transformed-table></extracted-table><extracted-table><table-id>hbm24878-tbl-0002</table-id><table-label>Table 2</table-label><table-caption>Demographic and clinical characteristics of patients with Parkinson's disease and healthy controls</table-caption><table-wrap-foot>Abbreviations: F: Female; LEDD: Levodopa equivalent daily dose; M: Male; MMSE: Mini mental status examination; UPDRS: Unified Parkinson's disease rating scale, *: UPDRS III (OFF score) was available for 110 subjects.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hbm24878-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Demographic and clinical characteristics of patients with Parkinson's disease and healthy controls</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Parkinson's disease (<italic toggle="yes">n</italic> = 133)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Healthy controls (<italic toggle="yes">n</italic> = 99)</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (M: F)</td><td align="left" valign="top" rowspan="1" colspan="1">104:29</td><td align="left" valign="top" rowspan="1" colspan="1">71:28</td><td align="left" valign="top" rowspan="1" colspan="1">0.257</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">54.19 ± 8.23</td><td align="left" valign="top" rowspan="1" colspan="1">52.34 ± 7.94</td><td align="left" valign="top" rowspan="1" colspan="1">.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age at onset</td><td align="left" valign="top" rowspan="1" colspan="1">48.70 ± 9.36</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration of illness</td><td align="left" valign="top" rowspan="1" colspan="1">5.08 ± 3.11</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MMSE</td><td align="left" valign="top" rowspan="1" colspan="1">27.22 ± 2.51</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRS III (OFF score) *</td><td align="left" valign="top" rowspan="1" colspan="1">34.68 ± 8.80</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LEDD</td><td align="left" valign="top" rowspan="1" colspan="1">598.39 ± 238.50</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot id="hbm24878-ntgp-0002"><fn id="hbm24878-note-0002"><p>Abbreviations: F: Female; LEDD: Levodopa equivalent daily dose; M: Male; MMSE: Mini mental status examination; UPDRS: Unified Parkinson's disease rating scale, *: UPDRS III (OFF score) was available for 110 subjects.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of patients with Parkinson's disease and healthy controls</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom"/><th align="left" valign="bottom">Parkinson's disease (n = 133)</th><th align="left" valign="bottom">Healthy controls (n = 99)</th><th align="left" valign="bottom">p value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">Gender (M: F)</td><td align="left" valign="top">104:29</td><td align="left" valign="top">71:28</td><td align="left" valign="top">0.257</td></tr><tr><td align="left" valign="top">Age</td><td align="left" valign="top">54.19 ± 8.23</td><td align="left" valign="top">52.34 ± 7.94</td><td align="left" valign="top">.08</td></tr><tr><td align="left" valign="top">Age at onset</td><td align="left" valign="top">48.70 ± 9.36</td><td align="left" valign="top">—</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top">Duration of illness</td><td align="left" valign="top">5.08 ± 3.11</td><td align="left" valign="top">—</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top">MMSE</td><td align="left" valign="top">27.22 ± 2.51</td><td align="left" valign="top">—</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top">UPDRS III (OFF score) *</td><td align="left" valign="top">34.68 ± 8.80</td><td align="left" valign="top">—</td><td align="left" valign="top">NA</td></tr><tr><td align="left" valign="top">LEDD</td><td align="left" valign="top">598.39 ± 238.50</td><td align="left" valign="top">—</td><td align="left" valign="top">NA</td></tr></tbody></table></div>Abbreviations: F: Female; LEDD: Levodopa equivalent daily dose; M: Male; MMSE: Mini mental status examination; UPDRS: Unified Parkinson's disease rating scale, *: UPDRS III (OFF score) was available for 110 subjects.</transformed-table></extracted-table><extracted-table><table-id>hbm24878-tbl-0003</table-id><table-label>Table 3</table-label><table-caption>FDR corrected (p‐value = .05) results of independent t test for diffusion measures between healthy controls and patients with Parkinson's disease</table-caption><table-wrap-foot>Abbreviations: AD: Axial diffusivity; ADL: AD of left SNc, ADR: AD of right SNc; FA: Fractional anisotropy; FAL: FA of left SNc; FAR: FA of right SNc; HC: Healthy controls; HCL: Left SNc of HC; HCR: Right SNc of HC; MD: Mean diffusivity; MDL: MD of left SNc; MDR: MD of right SNc; PD: Parkinson's disease; PDL: Left SNc of patients with PD, PDR: Right SNc of patients with PD; RD: Radial diffusivity; RDL: RD of left SNc, RDR: RD of right SNc; SD: Standard deviation; SNc: Substantia nigra pars compacta. </table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hbm24878-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>FDR corrected (<italic toggle="yes">p</italic>‐value = .05) results of independent <italic toggle="yes">t</italic> test for diffusion measures between healthy controls and patients with Parkinson's disease</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">PD</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">HC</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic>‐value</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic>‐value</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic>‐value</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th><th align="left" valign="bottom" rowspan="1" colspan="1">(mean ± <italic toggle="yes">SD</italic>)</th><th align="left" valign="bottom" rowspan="1" colspan="1">(mean ± <italic toggle="yes">SD</italic>)</th><th align="left" valign="bottom" rowspan="1" colspan="1">(PD vs HC)</th><th align="left" valign="bottom" rowspan="1" colspan="1">(PD<sub>L</sub> vs PD<sub>R</sub>)</th><th align="left" valign="bottom" rowspan="1" colspan="1">(HC<sub>L</sub> vs HC<sub>R</sub>)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">AD<sub>L</sub></td><td align="left" valign="top" rowspan="1" colspan="1">1.17 × 10<sup>−3</sup> ± 6.94 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.13 × 10<sup>−3</sup> ± 6.76 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.00002</td><td align="left" valign="top" rowspan="1" colspan="1">4.67e‐16</td><td align="left" valign="top" rowspan="1" colspan="1">1.43e‐07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AD<sub>R</sub></td><td align="left" valign="top" rowspan="1" colspan="1">1.1 × 10<sup>−3</sup> ± 5.76 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">1.08 × 10<sup>−3</sup> ± 5.93 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.0178</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FA<sub>L</sub></td><td align="left" valign="top" rowspan="1" colspan="1">4.06 × 10<sup>−1</sup> ± 2.59 × 10<sup>−2</sup></td><td align="left" valign="top" rowspan="1" colspan="1">4.03 × 10<sup>−1</sup> ± 3.07 × 10<sup>−2</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.5149</td><td align="left" valign="top" rowspan="1" colspan="1">1.24e‐04</td><td align="left" valign="top" rowspan="1" colspan="1">4.13e‐03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FA<sub>R</sub></td><td align="left" valign="top" rowspan="1" colspan="1">4.19 × 10<sup>−1</sup> ± 2.96 × 10<sup>−2</sup></td><td align="left" valign="top" rowspan="1" colspan="1">4.17 × 10<sup>−1</sup> ± 3.35 × 10<sup>−2</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.5149</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MD<sub>L</sub></td><td align="left" valign="top" rowspan="1" colspan="1">8.21 × 10<sup>−4</sup> ± 5.12 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">7.89 × 10<sup>−4</sup> ± 4.48 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.0000</td><td align="left" valign="top" rowspan="1" colspan="1">2.32e‐19</td><td align="left" valign="top" rowspan="1" colspan="1">1.57e‐13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MD<sub>R</sub></td><td align="left" valign="top" rowspan="1" colspan="1">7.63 × 10<sup>−4</sup> ± 4.45 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">7.42 × 10<sup>−4</sup> ± 3.64 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.0002</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RD<sub>L</sub></td><td align="left" valign="top" rowspan="1" colspan="1">6.49 × 10<sup>−4</sup> ± 4.72 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">6.21 × <sup>−4</sup> ± 3.91 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.0000</td><td align="left" valign="top" rowspan="1" colspan="1">5.48e‐19</td><td align="left" valign="top" rowspan="1" colspan="1">4.68e‐15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RD<sub>R</sub></td><td align="left" valign="top" rowspan="1" colspan="1">5.95 × 10<sup>−4</sup> ± 4.27 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">5.76 × <sup>−4</sup> ± 3.36 × 10<sup>−5</sup></td><td align="left" valign="top" rowspan="1" colspan="1">.0002</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr></tbody></table><table-wrap-foot id="hbm24878-ntgp-0003"><fn id="hbm24878-note-0003"><p>Abbreviations: AD: Axial diffusivity; AD<sub>L</sub>: AD of left SNc, AD<sub>R</sub>: AD of right SNc; FA: Fractional anisotropy; FA<sub>L</sub>: FA of left SNc; FA<sub>R</sub>: FA of right SNc; HC: Healthy controls; HC<sub>L</sub>: Left SNc of HC; HC<sub>R</sub>: Right SNc of HC; MD: Mean diffusivity; MD<sub>L</sub>: MD of left SNc; MD<sub>R</sub>: MD of right SNc; PD: Parkinson's disease; PD<sub>L</sub>: Left SNc of patients with PD, PD<sub>R</sub>: Right SNc of patients with PD; RD: Radial diffusivity; RD<sub>L</sub>: RD of left SNc, RD<sub>R</sub>: RD of right SNc; SD: Standard deviation; SNc: Substantia nigra pars compacta. </p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">FDR corrected (p‐value = .05) results of independent t test for diffusion measures between healthy controls and patients with Parkinson's disease</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom"/><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">PD</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">HC</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">p‐value</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">p‐value</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">p‐value</th></tr><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">(mean ± SD)</th><th align="left" valign="bottom">(mean ± SD)</th><th align="left" valign="bottom">(PD vs HC)</th><th align="left" valign="bottom">(PDL vs PDR)</th><th align="left" valign="bottom">(HCL vs HCR)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">ADL</td><td align="left" valign="top">1.17 × 10−3 ± 6.94 × 10−5</td><td align="left" valign="top">1.13 × 10−3 ± 6.76 × 10−5</td><td align="left" valign="top">.00002</td><td align="left" valign="top">4.67e‐16</td><td align="left" valign="top">1.43e‐07</td></tr><tr><td align="left" valign="top">ADR</td><td align="left" valign="top">1.1 × 10−3 ± 5.76 × 10−5</td><td align="left" valign="top">1.08 × 10−3 ± 5.93 × 10−5</td><td align="left" valign="top">.0178</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td align="left" valign="top">FAL</td><td align="left" valign="top">4.06 × 10−1 ± 2.59 × 10−2</td><td align="left" valign="top">4.03 × 10−1 ± 3.07 × 10−2</td><td align="left" valign="top">.5149</td><td align="left" valign="top">1.24e‐04</td><td align="left" valign="top">4.13e‐03</td></tr><tr><td align="left" valign="top">FAR</td><td align="left" valign="top">4.19 × 10−1 ± 2.96 × 10−2</td><td align="left" valign="top">4.17 × 10−1 ± 3.35 × 10−2</td><td align="left" valign="top">.5149</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td align="left" valign="top">MDL</td><td align="left" valign="top">8.21 × 10−4 ± 5.12 × 10−5</td><td align="left" valign="top">7.89 × 10−4 ± 4.48 × 10−5</td><td align="left" valign="top">.0000</td><td align="left" valign="top">2.32e‐19</td><td align="left" valign="top">1.57e‐13</td></tr><tr><td align="left" valign="top">MDR</td><td align="left" valign="top">7.63 × 10−4 ± 4.45 × 10−5</td><td align="left" valign="top">7.42 × 10−4 ± 3.64 × 10−5</td><td align="left" valign="top">.0002</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td align="left" valign="top">RDL</td><td align="left" valign="top">6.49 × 10−4 ± 4.72 × 10−5</td><td align="left" valign="top">6.21 × −4 ± 3.91 × 10−5</td><td align="left" valign="top">.0000</td><td align="left" valign="top">5.48e‐19</td><td align="left" valign="top">4.68e‐15</td></tr><tr><td align="left" valign="top">RDR</td><td align="left" valign="top">5.95 × 10−4 ± 4.27 × 10−5</td><td align="left" valign="top">5.76 × −4 ± 3.36 × 10−5</td><td align="left" valign="top">.0002</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr></tbody></table></div>Abbreviations: AD: Axial diffusivity; ADL: AD of left SNc, ADR: AD of right SNc; FA: Fractional anisotropy; FAL: FA of left SNc; FAR: FA of right SNc; HC: Healthy controls; HCL: Left SNc of HC; HCR: Right SNc of HC; MD: Mean diffusivity; MDL: MD of left SNc; MDR: MD of right SNc; PD: Parkinson's disease; PDL: Left SNc of patients with PD, PDR: Right SNc of patients with PD; RD: Radial diffusivity; RDL: RD of left SNc, RDR: RD of right SNc; SD: Standard deviation; SNc: Substantia nigra pars compacta. </transformed-table></extracted-table></extracted-tables-set>